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Abstract
Objectives—Previous experimental and epidemiological research suggests that maternal 
exposure to some organic solvents during pregnancy may increase the risk of fetal growth 
restriction (FGR). We evaluated the association between expert-assessed occupational solvent 
exposure and risk of small for gestational age (SGA) infants in a population-based sample of 
women in the National Birth Defects Prevention Study.
Methods—We analysed data from 2886 mothers and their infants born between 1997 and 2002. 
Job histories were self-reported. Probability of exposure to six chlorinated, three aromatic and one 
petroleum solvent was assessed by industrial hygienists. SGA was defined as birthweight<10th 
centile of birthweight-by-gestational age in a national reference. Logistic regression was used to 
estimate ORs and 95% CIs to assess the association between SGA and exposure to any solvent(s) 
or specific solvent classes, adjusting for maternal age and education.
Results—Approximately 8% of infants were SGA. Exposure prevalence to any solvent was 10% 
and 8% among mothers of SGA and non-SGA infants, respectively. Among women with ≥50% 
probability of exposure, we observed elevated but imprecise associations between SGA and 
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exposure to any solvent(s) (1.71; 0.86 to 3.40), chlorinated solvents (1.70; 0.69 to 4.01) and 
aromatic solvents (1.87; 0.78 to 4.50).
Conclusions—This is the first population-based study in the USA to investigate the potential 
association between FGR and assessed maternal occupational exposure to distinct classes of 
organic solvents during pregnancy. The potential associations observed between SGA and 
exposure to chlorinated and aromatic solvents are based on small numbers and merit further 
investigation.
Introduction
Organic solvents are one of the most ubiquitous exposures in the workplace due to their 
extensive applications across varied industries. This group of volatile, carbon-based 
chemicals are frequently used to dissolve or disperse other chemicals into mixtures, and can 
be found in numerous occupational, household and personal use products such as paints, 
fuels, adhesives, inks, cosmetics, pharmaceuticals, cleaning solutions and pesticides.1
As the number of women of reproductive age in the workforce continues to grow in the 
USA and elsewhere, understanding the potential reproductive and perinatal effects of 
solvent exposure is important. Experimental research in animal models has demonstrated 
that many organic solvents cross the placental barrier and can be embryotoxic, genotoxic 
and teratogenic; some have been classified as probable reproductive hazards.2 A number of 
recently published systematic reviews of environmental and occupational risk factors for 
reproductive outcomes indicate that in epidemiological studies, maternal solvent exposure 
during pregnancy has been inconsistently associated with various adverse outcomes among 
offspring, including fetal loss, reduced birthweight and birth defects.3–7
Fetal growth restriction (FGR), also called intrauterine growth restriction, is a condition in 
which a fetus does not achieve his or her genetically-determined growth potential in utero 
due to complicating factors such as placental pathology, maternal conditions during 
pregnancy, exogenous environmental insults or a combination thereof. Since FGR is often 
challenging to assess, surrogate measures of FGR at birth are frequently employed such as 
low birthweight (typically defined as birthweight <2500 g regardless of gestational age), 
term birthweight (≥37 weeks gestation) and small for gestational age (SGA), with SGA 
accounting for the expected distribution of weight for a given gestational week.8 Despite 
differences in assessment, compromised fetal growth is a useful predictor of perinatal 
morbidity and mortality, as well as a potential risk factor for adverse health conditions later 
in life.9
Several epidemiological studies of varied designs have investigated the association between 
maternal solvent exposure during pregnancy and FGR in offspring; many, but not all, have 
reported modest associations for exposure to ‘any solvent’ or individually assessed solvents. 
Study populations have ranged from occupational cohorts, such as petrochemical1011 and 
laboratory1213 workers, to geographically localised communities impacted by soil and 
drinking water contamination.1415 Though five population-based studies of occupational 
solvent exposure and FGR have been conducted to date, 6–20 only one was conducted in the 
USA.20 Owing to differences in industry practices and safety standards as well as local 
Desrosiers et al. Page 2
Occup Environ Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
government regulations, occupational exposure profiles may differ significantly between 
populations with regard to prevalence of exposure to individual solvents as well as relevant 
parameters such as frequency and dose. Such differences in exposure profiles may explain, 
at least in part, what are often interpreted as ‘inconsistent’ results across studies of maternal 
solvent exposure and adverse perinatal outcomes. Synthesis of results across studies is 
further impeded by critical differences in exposure assessment strategies, ranging from 
exclusive reliance on self-reported use of solvents and solvent-containing products, to expert 
review and application of complex job-exposure matrices.
The objective of this study was to investigate the association between FGR and expert-rated 
occupational exposure to chlorinated, petroleum, and aromatic solvents in a population-
based sample of women from eight US states.
Methods
Between 1997 and 2013, the US Centres for Disease Control and Prevention's National 
Centre for Birth Defects and Developmental Disabilities conducted the National Birth 
Defects Prevention Study (NBDPS), a large population-based case-control study exploring 
potential behavioural, clinical, environmental and genetic risk factors for major congenital 
malformations. Cases (live births, stillbirths and electively terminated fetuses with an 
eligible birth defect) and unmatched controls (non-malformed, live-born infants) were 
ascertained from the same geographical and temporal base population using standard study 
protocols across participating study centres.21 Since NBDPS control participants are 
generally representative of their base population,22 this group of mothers of non-malformed 
infants has been used to investigate the prevalence of exposures to a variety of risk factors 
for adverse pregnancy outcomes other than congenital anomalies.23–25
Study population
The study population for this analysis included mothers of NBDPS control infants with 
estimated dates of delivery (‘due dates’) between October 1997 and December 2002, and 
who resided in the study area in one of the following eight states: Arkansas, California, 
Georgia, Iowa, Massachusetts, New Jersey, New York and Texas. During this study period, 
three study centres randomly selected controls from hospital records by month and birth 
hospital, weighted by the number of births per hospital per year (CA, NY and TX); three 
centres randomly selected controls from electronic birth certificates by month weighted by 
the number of births per month per year (IA, MA and NJ); and two centres (AR and GA) 
switched from hospital to birth certificate selection beginning with January 2001 births. 
Following standardised procedures for recruitment and consent between 6 weeks and 24 
months after delivery, mothers were asked to participate in an hour-long computer-assisted 
telephone interview. The structured interview collected information about a variety of 
demographic, behavioural, nutritional, clinical and environmental factors before and during 
pregnancy. Average time-to-interview after delivery among mothers of control infants 
during this study period was 8 months. At the time of the interview, potential participants 
were excluded if the mother did not speak English or Spanish, if she had previously 
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participated in the NBDPS, if deceased, if incarcerated, if otherwise unable to answer the 
questions, if a donor or surrogate parent or if the infant was adopted or in foster care.
In this analysis, we included mothers of NBDPS control infants who participated in the 
telephone interview (68% of eligible women participated in the interview) and reported 
having at least one job anytime during pregnancy or the month before conception (73% of 
interviewed women reported employment). We excluded mothers with pregestational 
diabetes (n=20) as well as non-singleton pregnancies (n=97). Remaining were 2886 eligible 
mother–infant pairs. The NBDPS and this analysis were approved by the institutional review 
boards of the Centres for Disease Control and Prevention and all participating study centres.
Exposure characterisation
During the telephone interview, mothers were asked about employment during pregnancy 
and before conception. Employment was defined as compensated, volunteer or military 
service, including part-time work and work performed at home, for a duration of at least one 
consecutive month. Details of each reported job were recorded, including the employer, job 
title, primary tasks and duties, chemicals and machines handled on the job, dates of 
employment and hours and days worked per week. Jobs were then coded by occupation and 
industry according to the Standard Occupational Classification Manual (2000) and North 
American Industry Classification System (1997). Led by the National Institute for 
Occupational Safety and Health, a team of industrial hygienists (IH) and occupational 
epidemiologists developed era-specific (1997–1999; 2000–2002) and solvent-specific job-
exposure databases to assess probability of occupational exposure to 10 organic solvents, 
including three aromatic solvents (benzene, xylene, toluene), six chlorinated solvents 
(carbon tetrachloride; chloroform; methylene chloride; perchloroethylene; trichloroethylene; 
1,1,1-trichloroethane) and the petroleum-based mixture Stoddard solvent (also known as 
mineral spirits or white spirits). These highly detailed job-exposure databases were informed 
by an extensively reviewed collection of published reports that included direct 
measurements and determinants of exposure for various occupations and industries.26–28
Using the job-exposure databases as a reference, an IH then reviewed each job code and 
associated self-reported occupational information from the interview to determine an 
exposure classification for each solvent based on expected probability of exposure, defined 
as the likelihood that a specific job within an industry within the corresponding era had any 
exposure to the solvent of interest. For this analysis, we considered a mother-to-be exposed 
to a particular solvent if any of her jobs during pregnancy or the month before conception 
were classified as exposed (ie, exposure probability >0); she was considered unexposed to a 
particular solvent if all her jobs during this time were classified as unexposed to that solvent 
(ie, exposure probability=0).
Outcome classification
The primary approach taken in this study to assess FGR was to classify infants using the 
common surrogate measure for FGR, that is, SGA. We defined SGA as birthweight below 
the 10th centile for a given gestational age at delivery in weeks, using national standardised 
sex-specific and parity-specific birthweight curves for non-Hispanic black infants, non-
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Hispanic white infants, as well as infants of Hispanic ethnicity.2930 Both maternal parity 
(defined as the number of previous live births) and race/ethnicity were self-reported during 
the NBDPS interview. Infant sex and gestational age were obtained from birth certificates or 
medical records. Infants less than 20 weeks or greater than 44 weeks (n=8) were excluded 
from further analyses, as these gestational ages are considered out of range of the reference 
birthweight curves. Also excluded from further analyses were participants missing values 
for infant sex (n=2), parity (n=1) or birthweight (n=15).
To capture a shift in the mean of the predominant distribution of birthweight that could be 
potentially associated with solvent exposure, we also examined birthweight as a continuous 
outcome (in grams). Analyses of birthweight were conducted among term infants only (≥37 
weeks gestation) as an attempt to isolate growth-restricted infants from those born preterm 
for underlying causes other than FGR.
Statistical analysis
We first examined the distribution by SGA classification of the following maternal and 
infant characteristics of a priori interest based on known/suspected risk factors for FGR: 
maternal age at delivery, race/ethnicity, education, prepregnancy body mass index (BMI), 
tobacco and alcohol use, multivitamin intake, pregnancy intention, number of previous live 
births, gestational diabetes, infant sex and maternal residence at delivery (study centre).
We then examined the prevalence and patterns of estimated occupational exposure. Among 
women classified as exposed to any of the 10 assessed solvents, approximately 85% were 
assessed as exposed to more than one solvent. Previous exploration of within-person 
correlation in assigned exposure status among exposed mothers in this study population 
revealed that exposure status was highly correlated between individual solvents within 
solvent class.31 For example, among women considered to have exposure to any of the six 
assessed chlorinated solvents, 98% of those exposed to methylene chloride were also 
considered exposed to 1,1,1-trichloroethane. Since the independent effect of exposure to an 
isolated solvent could not be evaluated, we estimated effects of maternal exposure(s) 
grouped by solvent class (chlorinated; petroleum (Stoddard solvent); aromatic) and reported 
the distribution of exposure classifications for each of the 10 assessed solvents.
We used unconditional logistic regression to estimate the association between SGA and 
maternal exposure to solvent classes anytime during the month before conception through 
the end of pregnancy. In these analyses, we present both unadjusted ORs with 95% CIs as 
well as ORs adjusted by maternal age (referent category 26–35 years) and education 
(referent category >12 years), which were the only two factors associated with both solvent 
exposure and SGA in our data (χ2 p value<0.05). Linear regression was used to estimate the 
mean difference in term birthweight among infants of exposed mothers compared to infants 
of unexposed mothers. In all models, the unexposed group consisted of women who were 
considered unexposed to all solvents.
To assess the potential impact of exposure misclassification on our primary effect measure 
estimates (ie, ORs for the association between solvent exposure and SGA), we conducted a 
sensitivity analysis in which we restricted the study sample to include only women with a 
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probability of exposure of at least 50%, as determined by the IH during the exposure 
assessment process.
Statistical analyses were performed using SAS V.9.3 (2014, SAS Institute Inc, Cary, North 
Carolina, USA) and were independently replicated (see Acknowledgments).
Results
After accounting for the aforementioned exclusion criteria, the final analysis set consisted of 
2861 mother–infant pairs. Of these, 230 infants (80%) were classified as SGA. Table 1 
summarises the distributions of maternal and infant factors by SGA classification: mothers 
of SGA infants were significantly different than mothers of non-SGA infants with regard to 
age at delivery, education, prepregnancy BMI and smoking during pregnancy. Distributions 
of maternal race/ethnicity and number of previous live births also varied.
The prevalence of estimated occupational exposure to organic solvents during the month 
before conception through the end of the pregnancy was 10.1% among mothers of SGA 
infants and 8.4% among mothers of non-SGA infants (table 2). Exposure prevalence varied 
between and within solvent classes. Regardless of SGA classification, the highest prevalence 
of exposure was to the group of chlorinated solvents (7.9% of SGA infants; 7.2% of non-
SGA infants), whereas only 3% or fewer of the women were considered exposed to 
Stoddard or aromatic solvents. Within the solvent class, exposure prevalence to individual 
solvents varied considerably. For example, among women considered exposed to 
chlorinated solvents, most were considered exposed to methylene chloride and/or 1,1,1-
trichloroethane (6.3% each among non-SGA infants), with few considered exposed to 
carbon tetrachloride (<1%).
Table 3 presents results for the logistic regression analyses of SGA. Among women with 
any probability of exposure during the month before conception or pregnancy, exposure to 
any solvent(s) was not associated with SGA (adjusted OR=1.16; 95% CI 0.73 to 1.83). 
When examining exposure effects by solvent class, we did not observe an association with 
SGA for chlorinated solvents (1.03; 0.62 to 1.71) nor Stoddard solvent (0.98; 0.44 to 2.18). 
However, we observed a modest but imprecise increase in the odds of SGA among infants 
whose mothers were exposed to aromatic solvents (1.60; 0.71 to 3.58). The association with 
aromatic solvents was driven by assessed exposure to toluene and/or xylene: approximately 
3% of mothers of SGA-infants were considered exposed to toluene and/or xylene, compared 
to 2% of mothers of non-SGA infants. The proportion of mothers exposed to benzene was 
equal between groups (approximately 0.5%).
When restricting the study sample to only women with at least 50% probability of exposure 
(compared to women with no exposure to any solvent), the magnitude of the observed 
estimated effect estimates increased. Women with higher probability of exposure at work to 
any solvent (n=10) were 1.7 times more likely (95% CI 0.86 to 3.40) to deliver a growth-
restricted infant compared to women with no probability of exposure, after adjusting for 
maternal age and education (table 3). Of the seven women with assessed exposure to 
Stoddard solvent, none had ≥50% probability of exposure. Six women (33.3%) had a higher 
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probability of exposure to both chlorinated solvents and aromatic solvents. The estimated 
ORs for chlorinated solvents (1.70; 0.69 to 4.01) and aromatic solvents (1.87; 0.78 to 4.50) 
were both elevated but imprecise.
Maternal exposure to any solvent (or any solvent class) was not associated with a 
meaningful change in the distribution of term birthweight (table 4). The difference in mean 
birthweight at term after adjustment for maternal age and education between infants of 
mothers exposed to any solvent and infants of unexposed mothers was 16.1 g (95% CI −46.2 
to 78.4).
Discussion
In our population-based study of nearly 3000 mother–infant pairs from eight US states, we 
did not consistently observe strong evidence of an association between assessed maternal 
occupational exposure to organic solvents in general (combining any exposure to the 10 
solvents included in our occupational exposure assessment) during the peripregnancy period 
and FGR, defined as either SGA or change in mean birthweight at term. After adjusting for 
maternal age and education, the OR for any potential solvent exposure and SGA was 1.16 
(0.73 to 1.83; 23 exposed cases). However, when restricting the exposed group to only 
women with a job(s) considered to have a higher probability of exposure (≥50%), the 
observed association between SGA and exposure to any solvent increased in magnitude to 
1.71 (0.86 to 3.40; 10 exposed cases).
When considering any probability of exposure to each specific class of solvents 
(chlorinated; petroleum (Stoddard); aromatic), we observed a modest but imprecise increase 
in the odds of having an infant classified as SGA among women exposed to aromatic 
solvents in particular (1.60; 0.71 to 3.58). Among women with at least 50% probability of 
exposure to aromatic solvents, the OR increased to 1.87 (0.78 to 4.50). Similarly, for 
chlorinated solvents, the estimated OR increased from 1.03 (0.62 to 1.71) among women 
with any probability of exposure to 1.70 (0.69 to 4.01) among women with higher 
probability of exposure.
The observed association with aromatic solvents in our study population was driven 
specifically by assessed exposure to toluene and/or xylene. Posthoc analyses revealed that 
among the 58 women considered exposed to either toluene or xylene, all but one woman 
were considered exposed to both; estimating effects for exclusive exposure to either toluene 
or xylene was thus impossible. Both toluene and xylene have been linked in previous 
experimental and epidemiological studies with an increased risk of FGR and other adverse 
perinatal outcomes, particularly among pregnant women exposed to higher doses via 
recreational solvent abuse.1332–35
One of the first population-based investigations of maternal occupational solvent exposure 
as a potential risk factor for FGR was conducted in a small community in the San Jose area 
of California.20 This cross-sectional study of 1000 births (1980–1985) assigned exposure 
status based on self-report and job title, and reported an OR for low birth weight (LBW; 
defined <2500 g) of 2.86 (95% CI 0.89 to 9.12) based on only three exposed cases; no effect 
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for SGA was observed (OR not reported). During a similar time period (1987–1988), 
German investigators applied a job exposure matrix (JEM) to assess occupational solvent 
exposure in a cohort of approximately 3500 births originally assembled to investigate 
potential effects of the Chernobyl accident.19 Probability, intensity and frequency of 
exposure were accounted for, and a modest increase in the odds of SGA was reported for 
low (1.3; 0.6 to 2.5) and moderate (2.2; 0.8 to 6.1) exposure (no women were considered to 
have ‘high’ exposure). SGA as well as LBW (defined as <3000 g) were later examined in a 
Finnish case–control study (1996–1997; approximately 1500 births) in relation to self-
reported exposure to any solvents at work anytime during pregnancy or the 3 months 
before.18 In this study, the unadjusted ORs for SGA and LBW were 1.72 (1.08 to 2.69) and 
1.39 (0.87 to 2.13), respectively. As in our study, estimated effects reduced in magnitude 
after adjustment (SGA 1.67 (1.02 to 2.73); LBW 1.17 (0.71 to 1.93)), though the association 
between solvent exposure and SGA remained statistically significant. This less conservative 
definition of LBW (<3000 g) was then applied in a population-based cohort study in 
Rotterdam (2002–2006) in which exposure to ‘industrial solvents and dry cleaning agents’ 
was assessed for approximately 6000 pregnancies using a JEM and self-reported 
occupational histories obtained via interview; the OR for any solvent exposure and LBW 
was 1.21 (0.88 to 1.66).17 Most recently, a large population-based cohort study in a small 
Russian municipality (1973–2005; approximately 26 000 births) used job title to assign 
exposure to organic solvents (exposed jobs included only ‘painters, painter-plasterers, and 
spoolers’) and reported a significant decrease in mean birthweight (−52.7 g; −85.1 to −20.5) 
as well as a significant increase in the odds of LBW (1.68; 1.18 to 2.41) among mothers 
employed in an ‘exposed’ occupation during pregnancy.16
Minimising exposure misclassification—both differential and non-differential—is a critical 
concern when using indirect methods for retrospective exposure assessment to investigate 
occupational exposures experienced during pregnancy. A major strength of our study is that 
exposure to 10 specific solvents was assessed for each job that a mother reported having 
performed during pregnancy by a team of IH with the aid of highly detailed era-specific and 
solvent-specific job-exposure databases developed specifically for this study population. 
This exposure assessment strategy is much more comprehensive than relying on job title 
alone, and is also less vulnerable to the recall error and potential bias associated with 
exposure assignment based strictly on self-reported exposure to solvents and solvent-
containing products at work. Further, ours may be the first population-based study to 
investigate the potential effect on fetal growth of maternal occupational exposure to solvents 
grouped by chemical class; this is significant because solvent classes are known to often 
have unique toxicity profiles and also have different applications across occupations. 
Despite these advantages, our exposure assessment has limitations. We did not collect 
information about possible non-occupational exposure to solvents incurred via recreational 
activities, personal hobbies or environmental contamination. Further, our exposure 
classification for this analysis does not account for additional exposure parameters beyond 
probability of exposure, such as frequency and intensity of exposure, which could 
potentially modify the observed effects. Since our exposure and outcome are dichotomous, 
the expected effect of this limitation would be to dilute the intended exposure contrast and 
bias the observed effect measure estimates toward the null. We attempted to assess the 
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potential impact of such exposure misclassification on our results for our primary measure 
of growth restriction in infants, SGA, by restricting the sample of exposed women to only 
those with at least one job rated as having a higher probability of exposure (≥50%) by the IH 
during the exposure assessment process. This sensitivity analysis demonstrated that, despite 
a decrease in sample size, the magnitude of the association between solvent exposure and 
SGA increased for exposure to both chlorinated and aromatic solvents.
Another advantageous feature of this study is its multistate population-based design. Since 
the NBDPS reference population (ie, participants enrolled as ‘controls’) has been previously 
shown to be generally representative of its base population,22 and since the women enrolled 
in the study represent a wide range of occupations,36 we expect our results to have greater 
generalisability to the population of women in the USA who work during pregnancy than a 
study conducted within a focused geographic location or industry. This is important because 
heterogeneity in results across previous studies may be partly attributable to substantial 
differences in occupational exposure profiles. Owing to differences in industry practices and 
safety standards as well as local government regulations, one would expect the prevalence of 
exposure to individual solvents as well as associated parameters, such as concentrations in 
the workplace environment, to differ across geographic populations and occupational 
cohorts, both domestically and internationally. Of the previous population-based studies of 
occupational solvent exposure and FGR, only one has been conducted in the USA, in a small 
community within San Jose, California, USA;20 our study population is nearly three times 
larger and includes births from eight states across the country. Despite the relative size and 
representativeness of our study population, our results are, nevertheless, based on small 
numbers of exposed women—a limitation which is reflected in the imprecision of our effect 
measure estimates. For example, the potential association we observed in our data between 
SGA and exposure to toluene and xylene was based on only seven exposed mothers of SGA 
infants, six of whom were assigned a probability of exposure that was at least 50%. In the 
future, we hope to extend the occupational exposure assessment to mothers in the NBDPS 
through 2011, thereby substantially increasing our study size.
A further source of heterogeneity across previous studies is that the selected surrogate 
measure of FGR varies. Some studies have evaluated SGA,18–20 while others have 
considered LBW with a threshold of either 25001620 or 30001718 grams. In our study, we 
examined two measures of FGR: SGA and change in the distribution of term birthweight. To 
construct a measure of SGA in our study, we used national references that accounted for 
infant sex, maternal parity and race/ethnicity.2930 SGA can detect shifts in the residual 
distribution of birthweight that cause a higher (or lower) proportion of infants, regardless of 
gestational age, to fall into a high-risk group often defined by the 10th centile. Though the 
10% weight-for-gestational-age cut-point for SGA is standard for many clinical and research 
applications, estimating the association between maternal solvent exposure during 
pregnancy and SGA defined using other cut-points or reference populations (including 
internal standardisation) may produce different results.3738 A further limitation is that, as a 
measure of fetal growth, SGA does not distinguish between pathogenically growth-restricted 
fetuses and those who are simply born constitutionally smaller than the population average. 
Stratifying as we did by infant sex, maternal parity and race/ethnicity may help to mitigate 
this limitation to some degree, but other important factors (eg, maternal prepregnancy BMI) 
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were unaccounted. To examine shifts in the whole distribution of birthweight that perhaps 
may not be reflected in the residual age-adjusted distribution (as measured by SGA), we 
assessed the impact of solvent exposure on change in mean birthweight among infants born 
at term (≥37 weeks). Less than 5% of preterm births are clinically indicated for significant 
FGR,39 and singleton pregnancies with uncomplicated FGR are typically allowed to 
progress to early term or term (38–39 weeks).40 Thus, by restricting analyses of birthweight 
to term births only, we attempted to assess whether solvent exposure might impact 
birthweight via mechanisms that are independent from those leading to spontaneous or 
iatrogenic preterm birth. While other studies have examined LBW (defined as either <2500 
or <3000 g at any gestational age) to assess FGR,16–1820 this dichotomy is less informative 
since one cannot distinguish whether observed associations with LBW are due to differences 
in preterm delivery, differences in fetal size or both.41
In conclusion, we found that women in our study population assessed to have a higher 
probability of workplace exposure to chlorinated and aromatic solvents had a small 
increased risk for delivering a growth-restricted infant, though our effect estimates were 
based on small numbers of exposed women and thus imprecise. Despite the growing body of 
experimental and epidemiological studies on the developmental toxicity of organic solvents, 
it remains unclear whether levels encountered by pregnant women in the workplace in the 
USA increase the risk of FGR among offspring. The common limiting factor of previous 
population-based epidemiological studies of the association between maternal occupational 
exposure to solvents and FGR, including our study, is exposure misclassification inherent in 
indirect, retrospective exposure assessment. In the future, studies with improved exposure 
assessment, such as studies that could directly assess exposure using biomarkers in 
prospectively collected biological samples during pregnancy,42 should add a unique 
contribution to our understanding of the potential effects of solvent exposure during 
pregnancy.
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What this paper adds
• Previous research suggests that maternal exposure to some organic solvents 
during pregnancy may increase the risk of fetal growth restriction (FGR) in 
offspring. Limitations of previous studies include small study size and exclusive 
reliance on self-reported exposure.
• In a population-based sample of women from eight US states (1997–2002), we 
evaluated the association between expert-assessed probability of occupational 
exposure to 10 organic solvents using era-specific and solvent-specific exposure 
databases and measures of FGR at birth, including small for gestational age 
(SGA) and birthweight.
• Results of this study suggest that the odds of delivering an infant who is SGA 
may be modestly higher for women considered to have ≥50% probability of 
occupational exposure during pregnancy to any solvent(s) (1.71; 0.86 to 3.40), 
chlorinated solvents (1.70; 0.69 to 4.01) or aromatic solvents (1.87; 0.78 to 4.50) 
compared to women considered to have no occupational exposure to any 
solvent. No association was observed for women with any probability of 
exposure (>0%).
• We did not observe evidence of a strong association between maternal 
occupational organic solvent exposure during pregnancy and FGR among 
offspring. The potential associations observed between SGA and exposure to 
chlorinated and aromatic solvents among women considered by the expert raters 
to have a higher probability of exposure (≥50%) are based on small numbers and 
merit further investigation.
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Table 2
Prevalence of assessed occupational exposure to organic solvents during pregnancy 
among working mothers, stratified by small for gestational age* (SGA) classification 
among infants without birth defects, National Birth Defects Prevention Study, USA, 
1997–2002
SGA (n=230) non-SGA (n=2631)
n (%) n (%)
Any solvent 23 (10.1) 219 (8.4)
 Unknown exposure 3 21
Chlorinated solvents 18 (7.9) 188 (7.2)
 Carbon tetrachloride 1 (0.4) 6 (0.2)
 Chloroform 6 (2.6) 77 (3.0)
 Methylene chloride 15 (6.6) 165 (6.3)
 Perchloroethylene 10 (4.4) 98 (3.8)
 1,1,1-Trichloroethane 14 (6.2) 164 (6.3)
 Trichloroethylene 7 (3.1) 87 (3.3)
Stoddard solvent 7 (3.1) 74 (2.8)
Aromatic solvents 7 (3.1) 52 (2.0)
 Benzene 1 (0.4) 13 (0.5)
 Toluene 7 (3.1) 50 (1.9)
 Xylene 7 (3.1) 51 (2.0)
*
Defined as birthweight <10th centile for gestational age in weeks based on published sex-specific, parity-specific and race-specific standardised 
birthweight curves in national external reference populations.
Occup Environ Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Desrosiers et al. Page 18
Ta
bl
e 
3
A
ss
oc
ia
tio
n 
be
tw
ee
n 
as
se
ss
ed
 p
ro
ba
bi
lit
y 
of
 m
at
er
na
l o
cc
up
at
io
na
l e
xp
os
ur
e 
to
 o
rg
an
ic
 so
lv
en
ts
 d
ur
in
g 
pr
eg
na
nc
y 
an
d 
sm
al
l f
or
 g
es
ta
tio
na
l 
a
ge
*
 
(S
GA
) a
mo
ng
 in
fan
ts 
wi
th
ou
t b
irt
h d
efe
cts
, N
ati
on
al 
Bi
rth
 D
efe
cts
 Pr
ev
en
tio
n S
tu
dy
, U
SA
, 1
99
7–
20
02
A
ny
 p
ro
ba
bi
lit
y 
of
 e
xp
os
ur
e
Pr
ob
ab
ili
ty
 o
f e
xp
os
ur
e 
>5
0%
n
†
cO
R
(95
%
 C
I)
a
O
R
‡
(95
%
 C
I)
n
§
a
O
R
‡
(95
%
 C
I)
U
ne
xp
os
ed
 to
 a
ny
 so
lv
en
t
20
4
R
ef
er
en
ce
R
ef
er
en
ce
20
4
R
ef
er
en
ce
Ex
po
se
d 
to
 a
ny
 so
lv
en
t
23
1.
23
(0.
78
 to
 1.
94
)
1.
16
(0.
73
 to
 1.
83
)
10
1.
71
(0.
86
 to
 3.
40
)
 
Ch
lo
rin
at
ed
 so
lv
en
t(s
)
18
1.
12
(0.
68
 to
 1.
86
)
1.
03
(0.
62
 to
 1.
71
)
6
1.
70
(0.
69
 to
 4.
01
)
 
St
od
da
rd
 so
lv
en
t
7
1.
11
(0.
50
 to
 2.
44
)
0.
98
(0.
44
 to
 2.
18
)
0
N
E
 
A
ro
m
at
ic
 so
lv
en
t(s
)
7
1.
58
(0.
71
 to
 3.
52
)
1.
60
(0.
71
 to
 3.
58
)
6
1.
87
(0.
78
 to
 4.
50
)
*
D
ef
in
ed
 a
s b
irt
hw
ei
gh
t <
10
th
 c
en
til
e 
fo
r g
es
ta
tio
na
l a
ge
 in
 w
ee
ks
 b
as
ed
 o
n 
pu
bl
ish
ed
 se
x-
sp
ec
ifi
c,
 p
ar
ity
-s
pe
ci
fic
 a
nd
 ra
ce
-s
pe
ci
fic
 st
an
da
rd
ise
d 
bi
rth
w
ei
gh
t c
ur
ve
s i
n 
na
tio
na
l e
xt
er
na
l r
ef
er
en
ce
 
po
pu
la
tio
ns
.
† N
um
be
r o
f m
ot
he
rs
 o
f S
G
A
-in
fa
nt
s c
la
ss
ifi
ed
 a
s e
xp
os
ed
 to
 so
lv
en
ts.
‡ A
dju
ste
d f
or 
ma
ter
na
l a
ge
 (r
efe
ren
t=2
6–
35
 ye
ars
) a
nd
 ed
uc
ati
on
 (r
efe
ren
t≥1
2 y
ear
s).
§ N
um
be
r o
f m
ot
he
rs
 o
f S
G
A
-in
fa
nt
s w
ith
 ≥
1 
job
 as
ses
sed
 as
 pr
ob
ab
ilit
y o
f e
xp
osu
re 
≥5
0%
.
aO
R,
 a
dju
ste
d O
R;
 cO
R,
 cr
ud
e O
R;
 N
E, 
no
t e
sti
ma
ted
.
Occup Environ Med. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Desrosiers et al. Page 19
Ta
bl
e 
4
M
ea
n 
ch
an
ge
 in
 in
fa
nt
 b
ir
th
w
ei
gh
t a
t t
er
m
 (≥
37
 w
ee
ks
 ge
sta
tio
n)
 as
so
cia
ted
 w
ith
 es
tim
ate
d m
ate
rn
al 
oc
cu
pa
tio
na
l e
xp
os
ur
e t
o o
rg
an
ic 
so
lv
en
ts
 d
ur
in
g 
pr
eg
na
nc
y,
 N
at
io
na
l B
ir
th
 D
ef
ec
ts
 P
re
ve
nt
io
n 
St
ud
y,
 U
SA
, 1
99
7–
20
02
D
iff
er
en
ce
 in
 b
ir
th
w
ei
gh
t (
gr
am
s) 
Es
tim
ate
 (9
5%
CI
)
N
(%
)
M
ea
n
(S
D)
U
na
dju
ste
d
A
dju
ste
d*
To
ta
l n
um
be
r o
f i
nf
an
ts
26
59
 
U
nk
no
w
n 
ex
po
su
re
21
 
U
ne
xp
os
ed
24
16
(91
.6)
34
62
.3
(45
1.9
)
 
Ex
po
se
d 
to
 a
ny
 so
lv
en
t
22
2
(8.
4)
34
66
.6
(47
6.6
)
4.
3
(−
58
.1 
to 
66
.7)
16
.1
(−
46
.2 
to 
78
.4)
 
A
ny
 c
hl
or
in
at
ed
 so
lv
en
t
19
1
(7.
2)
34
67
.8
(47
0.3
)
5.
5
(−
61
.3 
to 
72
.3)
19
.9
(−
46
.9 
to 
86
.6)
 
St
od
da
rd
 so
lv
en
t
76
(2.
9)
34
92
.9
(42
3.8
)
30
.6
(−
72
.4 
to 
13
3.7
)
56
.2
(−
46
.7 
to 
15
9.0
)
 
A
ny
 a
ro
m
at
ic
 so
lv
en
t
54
(2.
0)
35
45
.4
(49
2.4
)
83
.1
(−
39
.1 
to 
20
5.3
)
87
.9
(−
33
.5 
to 
20
9.3
)
*
A
dju
ste
d f
or 
ma
ter
na
l a
ge
 (r
efe
ren
t=2
6–
35
 ye
ars
) a
nd
 ed
uc
ati
on
 (r
efe
ren
t≥1
2 y
ear
s).
Occup Environ Med. Author manuscript; available in PMC 2016 August 01.
